Alain Fourquet

发表

31 Brachytherapy boost parameters and local recurrence in breast cancer patients treated with conservative surgery and radiotherapy

M. Maher, François Campana, Emmanuelle Mouret-Fourme, 2001 .

The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer.

Pietro Panizza, Laura Martincich, Nadia Harbeck, 2012, European journal of cancer.

Use of deformable image fusion to allow better definition of tumor bed boost volume after oncoplastic breast surgery.

Vincent Servois, Fabien Reyal, Nathalie Fournier-Bidoz, 2011, Surgical oncology.

Risk of second malignancies after adjuvant radiotherapy for breast cancer: a large-scale, single-institution review.

Bernard Asselain, Yann De Rycke, Youlia M Kirova, 2007, International journal of radiation oncology, biology, physics.

A prognostic DNA signature for T1T2 node‐negative breast cancer patients

Anne Vincent-Salomon, Bernard Asselain, Olivier Delattre, 2010, Genes, chromosomes & cancer.

Improving the definition of tumor bed boost with the use of surgical clips and image registration in breast cancer patients.

Nathalie Fournier-Bidoz, Tarek Hijal, Youlia M Kirova, 2010, International journal of radiation oncology, biology, physics.

Male breast cancer

G. Hortobagyi, I. Fentiman, A. Fourquet, 1998, The Lancet.

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

Pierre-Marie Martin, Carole Mathelin, Fabrice André, 2011, Breast Cancer Research and Treatment.

Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer.

Laurence Collette, Rodrigo Arriagada, Erik Van Limbergen, 2015, The New England journal of medicine.

Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'.

Michel Bolla, Laurence Collette, John Kurtz, 2008, European journal of cancer.

Role of dynamic magnetic resonance imaging in the evaluation of tumor response to preoperative concurrent radiochemotherapy for large breast cancers: a prospective phase II study.

Martine Meunier, M. Bollet, V. Diéras, 2007, International journal of radiation oncology, biology, physics.

How to boost the breast tumor bed? A multidisciplinary approach in eight steps.

Vincent Servois, Nathalie Fournier-Bidoz, Youlia M Kirova, 2008, International journal of radiation oncology, biology, physics.

Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.

Dominique Stoppa-Lyonnet, Youlia M Kirova, D. Stoppa-Lyonnet, 2005, European journal of cancer.

Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature

Bernard Asselain, Dominique Stoppa-Lyonnet, B. Asselain, 2010, Breast Cancer Research and Treatment.

Genomic Instability: A Stronger Prognostic Marker Than Proliferation for Early Stage Luminal Breast Carcinomas

Roman Rouzier, Anne Vincent-Salomon, Guillem Rigaill, 2013, PloS one.

Analyzing prognostic factors in breast cancer using a multistate model

Philippe Broët, Bernard Asselain, Yann De Rycke, 1999, Breast Cancer Research and Treatment.

Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial

Laurence Collette, Jos J. Jager, Harry Bartelink, 2007 .

Search for a Gene Expression Signature of Breast Cancer Local Recurrence in Young Women

Emmanuel Barillot, Nicolas Servant, Philippe Hupé, 2012, Clinical Cancer Research.

High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers.

Emmanuel Barillot, Nicolas Servant, Philippe Hupé, 2008, Journal of the National Cancer Institute.